Swedish Orphan Biovitrum AB (publ) (LON:0MTD)
London flag London · Delayed Price · Currency is GBP · Price in SEK
261.19
-0.81 (-0.31%)
At close: Apr 17, 2025

LON:0MTD Revenue

In the year 2024, Swedish Orphan Biovitrum AB had annual revenue of 26.03B SEK with 17.65% growth. Swedish Orphan Biovitrum AB had revenue of 7.44B in the quarter ending December 31, 2024, with 8.65% growth.

Revenue
26.03B SEK
Revenue Growth
+17.65%
P/S Ratio
3.95
Revenue / Employee
14.41M SEK
Employees
1,806
Market Cap
7.41B GBP

Revenue Chart

* This company reports financials in SEK.

History

Fiscal Year End Revenue Change Growth
Dec 31, 202426.03B3.90B17.65%
Dec 31, 202322.12B3.33B17.74%
Dec 31, 202218.79B3.26B21.00%
Dec 31, 202115.53B268.00M1.76%
Dec 31, 202015.26B1.01B7.11%
Dec 31, 2019 Pro Pro Pro
Dec 31, 2018 Pro Pro Pro
Dec 31, 2017 Pro Pro Pro
Dec 31, 2016 Pro Pro Pro
Dec 31, 2015 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
AstraZeneca 43.19B
HSBC Holdings 48.93B
Shell 227.10B
Unilever 50.25B
Rio Tinto Group 42.86B
RELX PLC 9.43B
British American Tobacco p.l.c. 25.87B
Rolls-Royce Holdings 18.91B
Revenue Rankings